Menu
Back to User profile » Prof. Dr. Christopher Gillberg
Papers published by Prof. Dr. Christopher Gillberg:
Orexin/Hypocretin System Dysfunction in ESSENCE (Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations)
Knez R, Stevanovic D, Fernell E, Gillberg C
Neuropsychiatric Disease and Treatment 2022, 18:2683-2702
Published Date: 15 November 2022
How Accurately Does the Information on Motor Development Collected During Health Checkups for Infants Predict the Diagnosis of Neurodevelopmental Disorders? – A Bayesian Network Model-Based Study
Hatakenaka Y, Hachiya K, Ikezoe S, Åsberg Johnels J, Gillberg C
Neuropsychiatric Disease and Treatment 2022, 18:2405-2420
Published Date: 19 October 2022
The ESSENCE-Questionnaire for Neurodevelopmental Problems – A Swedish School-Based Validation Study in 11-Year-Old Children
Landgren V, Svensson L, Knez R, Theodosiou M, Gillberg C, Fernell E, Landgren M, Johnson M
Neuropsychiatric Disease and Treatment 2022, 18:2055-2067
Published Date: 15 September 2022
Indexing Executive Functions with Test Scores, Parent Ratings and ERPs: How Do the Measures Relate in Children versus Adolescents with ADHD?
Häger LA, Øgrim G, Danielsen M, Billstedt E, Gillberg C, Åsberg Johnels J
Neuropsychiatric Disease and Treatment 2020, 16:465-477
Published Date: 17 February 2020
Experiences Of Immigrant Parents In Sweden Participating In A Community Assessment And Intervention Program For Preschool Children With Autism
Nilses Å, Jingrot M, Linnsand P, Gillberg C, Nygren G
Neuropsychiatric Disease and Treatment 2019, 15:3397-3410
Published Date: 6 December 2019
Chronic Pain And Health-Related Quality Of Life In Women With Autism And/Or ADHD: A Prospective Longitudinal Study
Asztély K, Kopp S, Gillberg C, Waern M, Bergman S
Journal of Pain Research 2019, 12:2925-2932
Published Date: 18 October 2019
Health, functionality, and social support in families with a child with a neurodevelopmental disorder – a pilot study
Cavonius-Rintahaka D, Aho AL, Voutilainen A, Billstedt E, Gillberg C
Neuropsychiatric Disease and Treatment 2019, 15:1151-1161
Published Date: 8 May 2019
Children screening positive for language delay at 2.5 years: language disorder and developmental profiles
Schachinger-Lorentzon U, Kadesjö B, Gillberg C, Miniscalco C
Neuropsychiatric Disease and Treatment 2018, 14:3267-3277
Published Date: 28 November 2018
Speech and language profiles in 4- to 6-year-old children with early diagnosis of autism spectrum disorder without intellectual disability
Kjellmer L, Fernell E, Gillberg C, Norrelgen F
Neuropsychiatric Disease and Treatment 2018, 14:2415-2427
Published Date: 20 September 2018
Children with autism spectrum disorders and selective mutism [Corrigendum]
Steffenburg H, Steffenburg S, Gillberg C, Billstedt E
Neuropsychiatric Disease and Treatment 2018, 14:2305-2306
Published Date: 6 September 2018
ESSENCE-Q: Slavic language versions for developmental screening in young children
Stevanovic D, Knez R, Zorcec T, Anderluh M, Kodrič J, Petrov P, Hadžagić Ćatibušić F, Deljković A, Brkic Cvetkovic S, Vrljičak Davidovic N, Kuzmanić Šamija R, Đorić A, Gillberg C
Neuropsychiatric Disease and Treatment 2018, 14:2141-2148
Published Date: 23 August 2018
Children with autism spectrum disorders and selective mutism
Steffenburg H, Steffenburg S, Gillberg C, Billstedt E
Neuropsychiatric Disease and Treatment 2018, 14:1163-1169
Published Date: 7 May 2018
Children with borderline intellectual functioning and autism spectrum disorder: developmental trajectories from 4 to 11 years of age
Barnevik Olsson M, Holm A, Westerlund J, Lundholm Hedvall Å, Gillberg C, Fernell E
Neuropsychiatric Disease and Treatment 2017, 13:2519-2526
Published Date: 4 October 2017
ESSENCE-Q – used as a screening tool for neurodevelopmental problems in public health checkups for young children in south Japan
Hatakenaka Y, Ninomiya H, Billstedt E, Fernell E, Gillberg C
Neuropsychiatric Disease and Treatment 2017, 13:1271-1280
Published Date: 10 May 2017
Children who screen positive for autism at 2.5 years and receive early intervention: a prospective naturalistic 2-year outcome study
Spjut Jansson B, Miniscalco C, Westerlund J, Kantzer AK, Fernell E, Gillberg C
Neuropsychiatric Disease and Treatment 2016, 12:2255-2263
Published Date: 1 September 2016
ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan
Hatakenaka Y, Fernell E, Sakaguchi M, Ninomiya H, Fukunaga I, Gillberg C
Neuropsychiatric Disease and Treatment 2016, 12:1739-1746
Published Date: 14 July 2016
“Recovery” from the diagnosis of autism – and then?
Barnevik Olsson M, Westerlund J, Lundström S, Giacobini M, Fernell E, Gillberg C
Neuropsychiatric Disease and Treatment 2015, 11:999-1005
Published Date: 7 April 2015
Early diagnosis of autism and impact on prognosis: a narrative review
Fernell E, Eriksson MA, Gillberg C
Clinical Epidemiology 2013, 5:33-43
Published Date: 21 February 2013